Levy Richard (Director) plans to sell 5,682 MDGL shares, about $2.9M
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001950047-26-004992
- Approximate sale date: May 22, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Shares acquired by: Previously Exercised Stock Options
- 10b5-1 plan adopted: Feb 20, 2026
All of Levy Richard's insider filings, holdings and planned sales
Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):
- Sold 40 shares at $506.68 on May 22, 2026 · Form 4
- Sold 320 shares at $508.24 on May 22, 2026 · Form 4
- Sold 151 shares at $510.36 on May 22, 2026 · Form 4
- Sold 610 shares at $511.4 on May 22, 2026 · Form 4
- Sold 439 shares at $512.5 on May 22, 2026 · Form 4
- Sold 40 shares at $512.97 on May 22, 2026 · Form 4
- Sold 343 shares at $514.67 on May 22, 2026 · Form 4
- Sold 657 shares at $515.92 on May 22, 2026 · Form 4
- Sold 723 shares at $516.87 on May 22, 2026 · Form 4
- Sold 1,497 shares at $517.59 on May 22, 2026 · Form 4
- Sold 782 shares at $518.76 on May 22, 2026 · Form 4
- Sold 80 shares at $519.98 on May 22, 2026 · Form 4
Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Ionis Pharmaceuticals IONS public float $5.3B, Jun 30, 2025
- Repligen RGEN public float $6.0B, Jun 30, 2025
- Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
- Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
- Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
